ACE2 and COVID-19: A Mendelian randomization analysis confirmed that adiposity, particularly central adiposity (defined by increased waist-to-hip ratio), associates with risk of COVID-19 susceptibility, hospitalization, and disease severity, which is mediated at least partly by plasma ACE2 (110).